Comments

Provectus (PVCT) Stock Price, Quote, News & History

PVCTOTCQB

Logo brought to you by Benzinga Data

Trade with Public

$0.0626

0.002654.42%

At close: Dec 16, 4:00 PM EST

Overview

News Earnings Insider Trades Short Interest

Key Statistics

Open

$0.06

Volume / Avg.

96.52K / 240.27K

Day Range

$0.06 - $0.06

52 Wk Range

0.05 - 0.13

Market Cap

$26.31M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Provectus Biopharmaceuticals Inc News

Short Volatility Alert: Provectus Biopharm

On Monday, shares of Provectus Biopharm (OTC: PVCT) experienced volatile short activity. After the activity, the stock price went up +7.53% to $0.14. The overall sentiment for PVCT has been Bullish.

Christopher Sappo

Partner Content

Trading Volume In The OTCQB Venture Market Picks Up in December – A Summary Of OTC Market Group's Most Active List In December

On December 14th, the Federal Reserve hiked its key interest rate by 50 basis points. This was the first deceleration in rate hike increases in 2022; between March and November 2022, the interest rate had jumped 25 basis points, 50 basis points and then 75 points four times in a row in between each Federal Reserve meeting.

Provectus Will Report Data on PV-10 in Combo Therapy, T-Cell Mediated Immunity at AACR Meeting

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Key Statistics

Open

$0.06

Volume / Avg.

96.52K / 240.27K

Day Range

$0.06 - $0.06

52 Wk Range

0.05 - 0.13

Market Cap

$26.31M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Pharmaceuticals

Provectus Biopharmaceuticals Inc is a clinical-stage biotechnology company developing immunotherapy medicines for different diseases that are based on a class of synthetic small molecule immuno-catalysts called halogenated xanthenes (HXs). Its HX mol...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Provectus (PVCT) stock?

You can purchase shares of Provectus (OTCQB:PVCT) through any online brokerage.

View our list of the best stock brokerages

Who are Provectus (PVCT) competitors?

There are no as such competitors for Provectus.

What is the forecast, or price target, for Provectus (PVCT) stock?

There is no analysis for Provectus to provide a consensus price target.

What is the current price for Provectus (PVCT)?

The stock price for Provectus (OTCQB: PVCT) is $0.06261 last updated December 16, 2025 at 3:43 PM EST.

Does Provectus (PVCT) pay a dividend?

There are no upcoming dividends for Provectus.

When is Provectus (OTCQB:PVCT) reporting earnings?

Provectus does not have any upcoming earnings scheduled.

Is Provectus (PVCT) going to split?

There is no upcoming split for Provectus.

What sector and industry does Provectus (PVCT) operate in?

Provectus is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCQB.